AUTHOR=Han Hongdong , Chen Yanrong , Yang Hao , Cheng Wei , Zhang Sijing , Liu Yunting , Liu Qiuhong , Liu Dongfang , Yang Gangyi , Li Ke 

TITLE=Identification and Verification of Diagnostic Biomarkers for Glomerular Injury in Diabetic Nephropathy Based on Machine Learning Algorithms

JOURNAL=Frontiers in Endocrinology

VOLUME=Volume 13 - 2022

YEAR=2022

URL=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.876960

DOI=10.3389/fendo.2022.876960

ISSN=1664-2392

ABSTRACT=DDiabetic nephropathy (DN) is regarded as the leading cause of end-stage renal disease worldwide and lacks novel therapeutic targets. To screen and verify special biomarkers for glomerular injury in patients with DN, fifteen datasets were retrieved from the Gene Expression Omnibus (GEO) database, correspondingly divided into train and test cohorts and then merged. Using limma package, 140 differentially expressed genes (DEGs) were screened out between 81 glomerular DN samples and 41 normal ones from the train cohort. With the help of ConsensusClusterPlus and WGCNA packages, the 81 glomerular DN samples were distinctly divided into two subclusters, and two highly associated modules were identified. By using machine learning algorithms (LASSO, RF and SVM-RFE) and Venn diagram, two overlapping genes (PRKAR2B and TGFBI) were finally determined as potential biomarkers, which were further validated in external test datasets and the HFD/STZ-induced mouse models. Based on the biomarkers, the diagnostic model was developed with reliably predictive ability for diabetic glomerular injury. Enrichment analyses indicated the apparent abnormal immune status in patients with DN, and the two biomarkers played an important role in immune microenvironment. The identified biomarkers were demonstrated a meaningful correlation with the immune cells infiltration and renal function. In conclusion, two robust genes were identified as diagnostic biomarkers and may serve as potential targets for therapeutics of DN, which were closely associated with multiple immune cells.